McKesson/$MCK
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About McKesson
McKesson is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
- Ticker
- $MCK
- Sector
- Health
- Primary listing
- NYSE
- Employees
- 42,300
- Headquarters
- Irving, United States
- Website
- www.mckesson.com
McKesson Metrics
BasicAdvanced
$114B
26.17
$37.48
0.31
$3.40
0.38%
Price and volume
Market cap
$114B
Beta
0.31
52-week high
$1,030.27
52-week low
$723.68
Average daily volume
768K
Dividend rate
$3.40
Financial strength
Current ratio
0.893
Quick ratio
0.504
Long term debt to equity
-7.785
Total debt to equity
-9.067
Dividend payout ratio (TTM)
8.56%
Interest coverage (TTM)
23.41%
Profitability
EBITDA (TTM)
7,187
Gross margin (TTM)
3.63%
Net profit margin (TTM)
1.12%
Operating margin (TTM)
1.57%
Effective tax rate (TTM)
17.93%
Revenue per employee (TTM)
$9,720,000
Management effectiveness
Return on assets (TTM)
4.74%
Return on equity (TTM)
-489.83%
Valuation
Price to earnings (TTM)
26.169
Price to revenue (TTM)
0.291
Price to book
-26.84
Price to tangible book (TTM)
-5.83
Price to free cash flow (TTM)
19.482
Free cash flow yield (TTM)
5.13%
Free cash flow per share (TTM)
50.348
Dividend yield (TTM)
0.35%
Forward dividend yield
0.38%
Growth
Revenue change (TTM)
8.84%
Earnings per share change (TTM)
50.20%
3-year revenue growth (CAGR)
13.10%
10-year revenue growth (CAGR)
7.85%
3-year earnings per share growth (CAGR)
11.82%
10-year earnings per share growth (CAGR)
14.56%
3-year dividend per share growth (CAGR)
14.94%
10-year dividend per share growth (CAGR)
11.34%
What the Analysts think about McKesson
Analyst ratings (Buy, Hold, Sell) for McKesson stock.
Analyst projections of the future price of McKesson stock.
Bulls say / Bears say
McKesson beat first-quarter earnings estimates and raised its fiscal 2027 adjusted EPS outlook to $44.20–$45.00, implying 13%–15% growth. Revenue rose 8% to $105.4 billion. (Reuters)
McKesson returned $2.6 billion to shareholders in the first quarter, including $2.5 billion in share repurchases, and raised its quarterly dividend by 15% to $0.94. These distributions add to shareholder returns alongside the company’s growth investments. (McKesson)
McKesson has committed substantial capital to expansion, including a $2.25 billion Precision Medicine Group acquisition and a planned $1.4 billion investment for a minority stake in Option Care Health. The deals require approvals and their returns depend on successful execution and growth. (McKesson, McKesson)
Opioid-related litigation remains a material exposure: McKesson’s latest annual filing reported about $5.7 billion in accrued liabilities and described numerous ongoing claims with outcomes that can be difficult to predict. (MarketScreener, StockTitan)
Medical-Surgical Solutions is a soft spot: first-quarter adjusted operating profit fell 20% while revenue rose 4%. The planned separation of the segment adds execution and timing risk. (McKesson)
Data summarised monthly by Lightyear AI. Last updated on 28 Oct 2026.
McKesson Financial Performance
Revenues and expenses
McKesson Earnings Performance
Company profitability
Upcoming events
McKesson News
AllArticlesVideos
Funds containing McKesson
AllUSDEURGBP
Fund name | Fund size | $MCK weighting |
|---|---|---|
iShares MSCI World Health Care Sector Advanced€CBUF | $683M | 1.96% |
iShares MSCI World Health Care Sector Advanced£WHCA | $362M | 1.96% |
Invesco Health Care S&P US Select Sector$XLVS | $552M | 1.80% |
Invesco Health Care S&P US Select Sector£XLVP | $552M | 1.80% |
iShares S&P 500 Health Care Sector€IUHE | €125M | 1.72% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.